Business Wire02.27.19
IntriCon Corporation, a designer, developer, manufacturer, and distributor of miniature and micro-miniature body-worn devices, has hired Doug Pletcher as vice president of Medical Business Development.
Pletcher has more than 25 years of executive management and business development experience in the medical device industry. In this new role, Pletcher is responsible for sales and marketing of new product platforms into the medical biotelemetry market. Prior to joining IntriCon, he served as vice president of Business Development for Heraeus Medical Components, where he was responsible for all business development activities for Interventional Finished Devices.
“We are excited to welcome Doug to the IntriCon team,” said Mark S. Gorder, IntriCon’s president and CEO. “We identified the need for more investment and resources to expand our medical business. Doug’s more than two decades in the industry will help us leverage our micro-miniaturization, digital signal processing and ultra-low power wireless core competencies to grow this business. His comprehensive background in engineering, marketing and clinical is a perfect mix of expertise to drive future growth and diversification.”
Said Pletcher, “I am excited to join IntriCon, a company with a deep breadth of proprietary technology and a compelling future. I look forward to working with the team to advance the company’s growth strategy and drive shareholder value.”
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops, and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom, and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market.
Pletcher has more than 25 years of executive management and business development experience in the medical device industry. In this new role, Pletcher is responsible for sales and marketing of new product platforms into the medical biotelemetry market. Prior to joining IntriCon, he served as vice president of Business Development for Heraeus Medical Components, where he was responsible for all business development activities for Interventional Finished Devices.
“We are excited to welcome Doug to the IntriCon team,” said Mark S. Gorder, IntriCon’s president and CEO. “We identified the need for more investment and resources to expand our medical business. Doug’s more than two decades in the industry will help us leverage our micro-miniaturization, digital signal processing and ultra-low power wireless core competencies to grow this business. His comprehensive background in engineering, marketing and clinical is a perfect mix of expertise to drive future growth and diversification.”
Said Pletcher, “I am excited to join IntriCon, a company with a deep breadth of proprietary technology and a compelling future. I look forward to working with the team to advance the company’s growth strategy and drive shareholder value.”
Headquartered in Arden Hills, Minn., IntriCon Corporation designs, develops, and manufactures miniature and micro-miniature body-worn devices. These advanced products help medical, healthcare and professional communications companies meet the rising demand for smaller, more intelligent and better-connected devices. IntriCon has facilities in the United States, Asia, the United Kingdom, and Europe. The company’s common stock trades under the symbol “IIN” on the NASDAQ Global Market.
